3rd Annual reimagine Health Research Symposium: Intervention & Prevention

The 3rd Annual reimagine Health Research Symposium will focus on current topics in the areas of Intervention and Prevention of important diseases that are impacting humankind. The symposium will emphasize approaches for a variety of diseases and crises including COVID-19, cancer, opioid addiction, and the challenge of needing to develop novel antibiotics. Attendees will learn from and engage with leading experts who will present and discuss contemporary treatment and prevention strategies in the areas of drug discovery, vaccine development, addiction management, the use of artificial intelligence, as well as ethical and social factors contributing to these approaches.

 

Who is invited to this event?

The event is open to the public. We highly recommend researchers and healthcare professionals to attend. We also welcome students, educators and the general public to attend this valuable conference. Early registration is encouraged.

To request disability-related accommodations that would ensure your full participation in this event, please contact: COMPHX-ResearchOffice@arizona.edu.

Cost:

Thanks to our generous sponsors, the Arizona Biomedical Research Centre and the Flinn Foundation, there is no cost to attend the virtual symposium.

 

Location:

This symposium will take place virtually via Zoom Webinar hosted by The University of Arizona College of Medicine – Phoenix.

 

Website:

Visit our website to learn more about the speakers!

Keynote Speaker

 

Gary Nabel, MD, PhD

ModeX Therapeutics

Topic: Vaccines

 

Featured Speakers

 

Regina Barzilay, PhD

Massachusetts Institute of Technology

Topic: AI in Antibiotic Discovery and Oncology Drug Development

 

Julie E. Bauman, MD, MPH

University of Arizona Cancer Center

Topic: Cancer Immunotherapy

 

Jolene Bowers, PhD

Translational Genomics Research Institute

Topic: COVID-19 Genomic Epidemiology

 

Tom Broker, PhD

University of Alabama at Birmingham School of Medicine

Topic: Development of anti-HPV Drugs

 

Marilyn Glassberg, MD

University of Arizona College of Medicine – Phoenix

Topic: COVID-19 Clinical Trials and Pulmonary Fibrosis

 

William Holland, MD

Banner Health

Topic: Banner System Response to the COVID-19 Pandemic

 

Sam Lee, PhD

Cocrystal Pharma Inc.

Topic: Discovery and Development of Antivirals

 

Purnima Madhivanan, MBBS, MPH, PhD

UArizona Mel and Enid Zuckerman College of Public Health

Topic: HPV Vaccination

 

Grant McFadden, PhD

Arizona State University

Topic: Virotherapy

 

Terrence Stull, MD

Phoenix Children’s Hospital Research Institute

Topic: Bacterial Vaccine Polypeptides

 

Tricia Wright, MD, MS

University of California San Francisco

Topics: Addiction Medicine